sections

Wednesday, 21 February 2018

Anthony Hughes' s stories

Sort by: Newest firstOldest firstA-ZZ-A

  • Elevate Credit logo

    Elevate lowers sights with fresh IPO

    Top News | 31 March 2017

    Lender seeks to overcome stumbles

  • Friends of Apollo cash in US$1.3bn from Athene sale

    Equities | 31 March 2017

    Athene Holding tested the meaning of an IPO lock-up as shareholders sold just 110 days following the float last December. The sale is all the more remarkable as shareholders in the Apollo-controlled fixed annuities provider had agreed to staggered lock-ups lasting two years.

  • Elevate cuts valuation in fresh IPO pitch

    Ticker | 28 March 2017

    Non-prime online lender Elevate Credit is having another stab at going public, just over a year after jitters in the industry and a stock market correction foiled its first attempt.

  • Market turn presents ECM challenges

    Equities | 24 March 2017

    Tuesday’s US stock market sell-off, the biggest fall in the major averages so far in 2017, gave ECM syndicate desks and investors reason for pause and cast a cloud over the near-term deal pipeline.

  • Alteryx secures top-end pricing

    Equities | 24 March 2017

    Alteryx drew more than 20 times subscription for its US$126m IPO last week, with the overflowing demand ensuring the self-service data analytics software company made a solid NYSE debut on Friday.

  • Keysight secures US$400m for Ixia buy

    Equities | 24 March 2017

    Keysight Technologies defied a sharp market decline last week to price a US$400m stock sale, the company’s first visit to equity capital markets since being spun off from Agilent Technologies in 2014.

  • Abbott slices Mylan stake with $1.7bn block

    Equities | 24 March 2017

    Abbott Laboratories has sold more than 60% of its remaining stake in EpiPen maker Mylan in a US$1.76bn unregistered block trade via Morgan Stanley, one of the largest ever stock sales in this format.

  • Cherry Hill stock sale blossoms too early

    Equities | 24 March 2017

    Mortgage REIT Cherry Hill Mortgage inadvertently gave eagle-eyed investors a premature heads-up on a US$74.3m follow-on stock sale launched after the close on Wednesday.

  • Abbott offloads Mylan stake via US$1.7bn overnight block

    Ticker | 23 March 2017

    Abbott Laboratories has sold more than 60% of its remaining stake in EpiPen maker Mylan in a US$1.7bn unregistered block trade via Morgan Stanley, one of the largest-ever commitments in this format.

  • Keysight pre-funds Ixia acquisition

    Ticker | 21 March 2017

    Keysight Technologies launched a US$400m marketed equity raise late Monday, its first as an independent entity since being spun off from Agilent Technologies in 2014.